Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Anesthesia

Trial Information

The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy

Official Title: The Effect of Rocuronium on the Response of Composite Variability Index (CVI) to Laryngoscopy

Summary

The Bispectral Index monitor is used in many operating rooms to provide information to the anesthesiologist about a patient's level of consciousness. The Composite Variability Index, or Composite Variability Index (CVI), is a new index that may provide the anesthesiologist with more information about the condition of the patient. The purpose of this study is to determine if a commonly used anesthetic drug (rocuronium) affects the CVI measurement differently with different doses. Rocuronium is a muscle relaxant routinely used during surgery. It is expected that the group given the highest dose of rocuronium will have diminished CVI values.

Phase: N/A

Sponsor: Covidien

Overall Contacts:

Jacquelyn Conace
781-690-8607

Locations (1)

Country State City Zip Facility and Contact
United States Vermont Burlington 05405 Fletcher Allen Health Care

Donald Mathews, MD
Principal Investigator

NCT ID:NCT01450813

Date Last Changed: November 27, 2012